Desktop Health Announces First Patients Treated With FDA-Cleared CMFlex – An Off-The-Shelf 3D Printed Synthetic Bone Graft Product Pioneered By Dimension Inx On The 3D-Bioplotter
Portfolio Pulse from Benzinga Newsdesk
Desktop Health, a brand of Desktop Metal, Inc. (NYSE:DM), announced the first patients have been treated with CMFlex, a 3D printed synthetic bone graft product developed by Dimension Inx. CMFlex, which received FDA clearance in December 2022, has been used in jaw surgeries and dental socket preservation cases. Dimension Inx, which owns four Desktop Health 3D-Bioplotters, has been developing CMFlex since 2009. The product is currently available to select surgeons, with a broader release expected in 2024.
November 29, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Desktop Metal, Inc. (NYSE:DM) has successfully treated patients with CMFlex, a 3D printed bone graft product, indicating progress in their healthcare division and potential revenue growth from broader release in 2024.
The successful treatment of patients with CMFlex represents a significant milestone for Desktop Metal's healthcare brand, Desktop Health. The FDA clearance and the product's use in surgeries demonstrate the company's advancement in the medical 3D printing market. This news is likely to be viewed positively by investors, as it suggests potential for future revenue growth, especially with a broader release planned for 2024. The direct involvement of Desktop Metal's technology in the development and manufacturing of CMFlex underscores the relevance of this news to the company.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90